Idiopathic Oligoasthenoteratospermia
Conditions
Interventions
Control group:Placebo
Sponsors
Jinling Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Diagnosed as oligoasthenospermia according to the World Health Organization Laboratory Manual for Human Semen Examination and Treatment (5th edition); 2.Initial examination and reexamination of abnormal semen quality shall meet one of the following conditions: sperm density 5×10^6;
Exclusion criteria
Exclusion criteria: Leucospermia, with testis, epididymitis, prostatitis, severe genital trauma, testicular torsion, urinary tract infection, cryptorchidism, varicocele, and a history of serious medical conditions such as diabetes, tumor history, inguinal and genital surgery. Testicular volume 32. Chromosomal karyotype abnormalities. Patients with Yin deficiency syndrome (clinical features: dry mouth and pharynx, five upset heat, prone to oral ulcers, slightly red and slightly dry tongue). Patients with endocrine diseases. Exposure to an occupation or environment with reproductive toxicity. Drug therapy to improve semen quality has been used in the past 2 weeks. Hepatobiliary disease, severe renal insufficiency, clinical disease or history of medication known to reduce fertility. A known or suspected history of allergy to experimental drugs and similar products. Any circumstance that the investigator considers to be likely to interfere with participation in the study or assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total sperm count in forward motion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sperm DNA fragmentation rate; | — |
Countries
China
Contacts
Public ContactYao Bing
Jinling Hospital
Outcome results
None listed